Literature DB >> 18605763

Pulmonary preneoplasia.

Sanja Dacic1.   

Abstract

CONTEXT: Improved screening techniques for lung cancer have resulted in detection of lesions that are considered to represent precursors of invasive lung carcinomas. These lesions may cause a diagnostic dilemma particularly on small biopsy or cytology specimens. Ancillary studies are usually not helpful, and diagnosis is based on morphology alone. Recognition of these lesions is very important to prevent potential diagnostic mistakes that may result in inadequate patient management. Future molecular studies may provide clinically useful diagnostic and prognostic gene markers.
OBJECTIVE: To review currently proposed morphologic criteria for precursor lesions of non-small cell lung carcinomas including squamous dysplasias, atypical adenomatous hyperplasia, and diffuse idiopathic neuroendocrine cell hyperplasia. Major molecular abnormalities are briefly discussed. DATA SOURCES: Published literature and recent World Health Organization classification of lung tumors.
CONCLUSIONS: Practicing surgical pathologists must be familiar with morphology of recognized pulmonary preneoplastic lesions that are more frequently detected radiographically and subjected to diagnostic procedures. Future understanding of underlying molecular abnormalities associated with progression of these lesions into invasive lung carcinoma may result in a development of molecular assays with potential diagnostic and prognostic importance.

Entities:  

Mesh:

Year:  2008        PMID: 18605763     DOI: 10.5858/2008-132-1073-PP

Source DB:  PubMed          Journal:  Arch Pathol Lab Med        ISSN: 0003-9985            Impact factor:   5.534


  8 in total

Review 1.  [Preneoplastic lesions of pulmonary carcinoma].

Authors:  L Bubendorf
Journal:  Pathologe       Date:  2011-11       Impact factor: 1.011

Review 2.  Cardiothoracic manifestations of neuroendocrine tumours.

Authors:  Ramin Mandegaran; Sarojini David; Nicholas Screaton
Journal:  Br J Radiol       Date:  2016-01-19       Impact factor: 3.039

3.  Tissue proteomics reveals differential and compartment-specific expression of the homologs transgelin and transgelin-2 in lung adenocarcinoma and its stroma.

Authors:  Jung-Hyun Rho; Michael H A Roehrl; Julia Y Wang
Journal:  J Proteome Res       Date:  2009-12       Impact factor: 4.466

Review 4.  Chemoprevention of lung cancer.

Authors:  Robert L Keith
Journal:  Proc Am Thorac Soc       Date:  2009-04-15

5.  Recurrence of squamous cell lung carcinoma is associated with the co-presence of reactive lesions in tumor-adjacent bronchial epithelium.

Authors:  Olga V Pankova; Evgeny V Denisov; Anastasia A Ponomaryova; Tatiana S Gerashchenko; Sergey A Tuzikov; Vladimir M Perelmuter
Journal:  Tumour Biol       Date:  2015-10-11

6.  Paxillin expression and amplification in early lung lesions of high-risk patients, lung adenocarcinoma and metastatic disease.

Authors:  Alexander C Mackinnon; Maria Tretiakova; Les Henderson; Rajendra G Mehta; Benjamin C Yan; Loren Joseph; Thomas Krausz; Aliya N Husain; Mary E Reid; Ravi Salgia
Journal:  J Clin Pathol       Date:  2010-11-02       Impact factor: 3.411

7.  NTCU induced pre-malignant and malignant stages of lung squamous cell carcinoma in mice model.

Authors:  Muhammad Asyaari Zakaria; Nor Fadilah Rajab; Eng Wee Chua; Gayathri Thevi Selvarajah; Siti Fathiah Masre
Journal:  Sci Rep       Date:  2021-11-18       Impact factor: 4.379

8.  Neoadjuvant chemotherapy combined with intraoperative radiotherapy is effective to prevent recurrence in high-risk non-small cell lung cancer (NSCLC) patients.

Authors:  Olga V Pankova; Evgeny O Rodionov; Sergey V Miller; Sergey A Tuzikov; Liubov A Tashireva; Tatiana S Gerashchenko; Evgeny V Denisov; Vladimir M Perelmuter
Journal:  Transl Lung Cancer Res       Date:  2020-08
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.